Ocular Therapeutix, Inc. (OCUL) Q3 2026 earnings results
Ocular Therapeutix, Inc. (OCUL) reported Q3 2026 results on Nov 9, 2026, 7:08:28 AM ET: GAAP EPS -$0.42 vs. -$0.35 expected (miss by 18.4%); revenue $12.87M vs. $14.30M expected (miss by 10.0%).
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.42 | -$0.35 | Miss by 18.4% |
| Revenue | $12.87M | $14.30M | Miss by 10.0% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 9, 2026, 7:08:28 AM ET. Nexqual published them 54 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 11.5% from $14.54M; GAAP diluted EPS was -$0.42 vs. -$0.38 (−10.5%).
Stock reaction
The results came out before the market opened. OCUL closed at $6.85 on November 9, 2026, up 3.9% from its $6.59 close on November 6, 2026 before the results. Latest: $6.66 as of 11:32 AM ET, +1.0% since the pre-release close.
Questions and answers
Did Ocular Therapeutix, Inc. beat earnings expectations?
No. Ocular Therapeutix, Inc. reported GAAP EPS of -$0.42 against an average analyst estimate of -$0.35 (miss by 18.4%), and revenue of $12.87M against $14.30M expected (miss by 10.0%).
What were Ocular Therapeutix, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.42 and revenue of $12.87M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 11.5% from $14.54M; GAAP diluted EPS was -$0.42 vs. -$0.38 (−10.5%).
When did Ocular Therapeutix, Inc. report Q3 2026 earnings?
Nov 9, 2026, 7:08:28 AM ET, in an SEC 8-K filing (Item 2.02).
How did OCUL stock react to the earnings?
The results came out before the market opened. OCUL closed at $6.85 on November 9, 2026, up 3.9% from its $6.59 close on November 6, 2026 before the results. Latest: $6.66 as of 11:32 AM ET, +1.0% since the pre-release close.
More on OCUL
OCUL stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 9, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:32 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:32 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt